| Latest Forum Topics / Grand Venture |
 Post Reply
|
|
EXPANSION INTO THE MEDICAL INDUSTRY FOR GROWTH
|
|||||
|
Alignment
Elite |
12-Nov-2025 11:53
|
||||
|
x 0
x 1 Alert Admin |
The dutch buyer was lucky this deal closed before the dutch government tried to steal nexperia from a chinese company. If not it might have been caught up in the subsequent horsetrading. | ||||
| Useful To Me Not Useful To Me | |||||
|
cumzilla
Member |
31-Oct-2025 22:05
|
||||
|
x 0
x 0 Alert Admin |
Has anyone receive the payment today? Yet to receive but mine is a custodian account, not CDP. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
spursfan
Supreme |
03-Oct-2025 21:03
|
||||
|
x 0
x 0 Alert Admin |
the court has approved the scheme offer today last day of trading of the Shares will be on 8 October 2025 Expected date for the payment of the Scheme Consideration: On or around 31 October 2025 https://links.sgx.com/1.0.0/corporate-announcements/JLKJCYK2W3AY435P/860961_GVT%20-%20Court%20Approval.pdf |
||||
| Useful To Me Not Useful To Me | |||||
|
spursfan
Supreme |
17-Sep-2025 19:21
|
||||
|
x 0
x 0 Alert Admin |
scheme offer was approved at today meeting RESULTS OF THE SCHEME MEETING https://links.sgx.com/1.0.0/corporate-announcements/J3PG2D2URQCE56L2/859307_GVT%20-%20Results%20of%20Scheme%20Meeting.pdf |
||||
| Useful To Me Not Useful To Me | |||||
|
spursfan
Supreme |
12-Sep-2025 10:53
|
||||
|
x 0
x 0 Alert Admin |
the schem meeting is on 17 sept. if the shareholders approve the offer at the meeting and thereafter athe court grant the approval . it will be game over. meetng details https://links.sgx.com/1.0.0/corporate-announcements/FZR3ID235H60M8FZ/5b6beca5697c9b265917befc03dee521d22b0d4d8ea7d9dbf5d19e14d4e605f3
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sgvale
Supreme |
12-Sep-2025 10:44
|
||||
|
x 0
x 0 Alert Admin |
Can the offer be rejected? Higher price envisage | ||||
| Useful To Me Not Useful To Me | |||||
|
cumzilla
Member |
28-Aug-2025 08:55
|
||||
|
x 0
x 0 Alert Admin |
4% from SCB Bonu$aver account' s interest for the 1st 100k, actually is 2.5% to be exact for the investment category + 1.5% salary credit....
|
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
27-Aug-2025 21:29
|
||||
|
x 0
x 0 Alert Admin |
How do you get 4%? The offer is 94 and the shares can be bought at 92.5.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
cumzilla
Member |
26-Aug-2025 11:40
|
||||
|
x 0
x 0 Alert Admin |
Buying 20K of this for my SCB Bonu$aver account to earn 4% for the next 6 months | ||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
25-Aug-2025 17:36
|
||||
|
x 0
x 0 Alert Admin |
Quiet as a mouse. | ||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
20-Aug-2025 11:00
|
||||
|
x 0
x 0 Alert Admin |
Expect the unexpected for better counter offer $1. | ||||
| Useful To Me Not Useful To Me | |||||
|
luckyguy3
Master |
27-Jul-2025 17:24
|
||||
|
x 0
x 0 Alert Admin |
buy this counter and waiti for the POTENTIAL 2 cents profit or a higher offer that most likely will never come and watch other counters rocket more than 10 cents?
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sgvale
Supreme |
27-Jul-2025 17:20
|
||||
|
x 0
x 0 Alert Admin |
Offer 0.94. Bought at 0.92 is no brainer . Wait for better offer while others counters to keep climbing for apparent gap widen.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
27-Jul-2025 00:52
|
||||
|
x 0
x 0 Alert Admin |
There is space in my portfolio for both GVT on the one hand and UMS/Frencken/AEM/Innotek on the other hand. The investment thesis and risk profile of GVT is different from the others - GVT is a pure play M& A trade betting that another bidder will come out with a higher price. The downside case is 94 cents i.e. a small upside from here by year end. The other shares offer much greater upside but also potential market volatility risk. People can choose which they prefer but for me there is diversiifcation benefit from holding both. |
||||
| Useful To Me Not Useful To Me | |||||
|
stlimst
Master |
25-Jul-2025 15:50
|
||||
|
x 0
x 0 Alert Admin |
Good for you. Hope GVT moves beyond 94 cents.
As for me, I will not buy back as think management doesn't have the foresight. Good luck to you.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
25-Jul-2025 15:31
|
||||
|
x 0
x 0 Alert Admin |
I bought back GVT 0.92 2 days back. Hopefully got someone offer higher | ||||
| Useful To Me Not Useful To Me | |||||
|
Professor001
Member |
24-Jul-2025 10:41
|
||||
|
x 0
x 0 Alert Admin |
My pick is AEM. It seems AEM has a better potential medium term, i.e. 2-years horizon, once their production volume can be ramped up for new customers. Also, Intel' s 2nd quarter results release on 24 Jul after market close might provide a catalyst for AEM share price to rise further, since AEM' s fortune is tied closely to Intel for now. For now, slowly accumulate on weakness.
|
||||
| Useful To Me Not Useful To Me | |||||
|
stlimst
Master |
24-Jul-2025 08:46
|
||||
|
x 0
x 0 Alert Admin |
I have given up on GVT and move on to Frencken. The semiconductor peers are all dashing ahead.
On paper, my profit from this shift is more than GVT at $1. Good thing I recycle my capital rather than stuck at 94 cents in GVT. Management and major shareholders misread the situation which only benefitted Aalbert |
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
24-Jul-2025 06:55
|
||||
|
x 0
x 0 Alert Admin |
It' s not attractive for us to sell at 94 cents sure, but that cat is already out of the bag as enough shareholders have given irrevocables to ensure the deal will almost certainly go through (ie the rest of us will be forced to sell at 94 cents) without a higher bid from someone else stepping forward. That is our only hope now. | ||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
24-Jul-2025 06:50
|
||||
|
x 0
x 0 Alert Admin |
Seeing how AEM, UMS & Frencken run up, GVT offer at 0.94 is not the least attractive. DBS target of GVT $1.20+ should be easily surpassed ~ $1.28 likely. | ||||
| Useful To Me Not Useful To Me | |||||